Abstract: This review discusses staging, etiology, prognostic factor and surgical treatment modalities available for esophageal cancer. We searched for articles published through December, 2017 in the following five electronic databases: PubMed, Science Direct, Embase, Web of Science, and Scopus, for both English and non-English language articles with the following keywords: “esophageal cancer”, “amputations”, “esophagectomy”, “surgical management”. Esophageal cancer is a severe malignancy with regards to mortality and prognosis. Esophageal cancer is staged according to the widely accepted TNM system. Surgical resection continues to be the major therapy for potentially treatable esophageal cancer. Neoadjuvant treatment can improve longterm end result after esophagectomy. Additionally, MIE could improve temporary end result, and 3-field lymph node dissection could reduce the risk of recurrence. Staging plays an integral part in directing stage specific therapy protocols and has a good influence on total survival. Usual imaging modalities utilized in staging consist of CT, EUS and PET scans. Present treatment choices consist of multimodality treatment mainstays of present therapy include surgery, radiation and chemotherapy. The progress made in surgery lead surgeons to consider minimal techniques to reduce morbidity and mortality of such high-risk procedures. New techniques of MIE and robotic surgery in a close to future will certainly offer chance to push the boundary of the indications in very selected group of patients.
Keywords: MIE, “esophageal cancer”, “amputations”, “esophagectomy”, “surgical management”.
Title: Surgical Esophagectomy Management of Esophageal Cancer: A Review
Author: Abdullah Ayed Al_Nefaie, Manal Ahmad Assiri
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
